NOVANTA INC·4

Jul 7, 4:05 PM ET

Glastra Matthijs 4

4 · NOVANTA INC · Filed Jul 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Novanta (NOVT) CEO Matthijs Glastra Sells 6,500 Shares

What Happened Matthijs Glastra, CEO of Novanta Inc. (NOVT), sold a total of 6,500 shares in open-market transactions on July 2, 2026 for aggregate proceeds of approximately $1,047,340. The sales were reported in five tranches: 3,024 shares at a weighted-average $160.13 ($484,233); 1,672 shares at $161.28 ($269,660); 1,167 shares at $162.01 ($189,066); 437 shares at $163.71 ($71,541); and 200 shares at $164.20 ($32,840). A power of attorney is on file for the filer.

Key Details

  • Transaction date: July 2, 2026; Form 4 filed July 7, 2026 (filed one business day late).
  • Prices/ranges: reported weighted-average prices per tranche; underlying trade ranges were $159.72–$160.66, $160.74–$161.74, $161.83–$162.76, and $163.09–$163.95 (detailed per-footnote).
  • Total shares sold: 6,500; total proceeds: ~$1.05 million.
  • Shares owned after transaction: not specified in the information provided here (see the filed Form 4 for holdings).
  • Notable footnote: Sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted Sept 11, 2025 (through a trust for which the reporting person’s spouse is trustee). The filer offers to provide detailed per-trade counts/prices upon request.

Context These were sales (not purchases or option exercises) executed under a pre-set 10b5-1 plan, which is commonly used to automate insider trades and reduce concerns about trading on material non-public information. The late filing (one business day past the 2-business-day Form 4 deadline) is noted in the record; investors may review the full Form 4 for any additional details.

Insider Transaction Report

Form 4
Period: 2026-07-02
Glastra Matthijs
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-07-02$160.13/sh3,024$484,23333,237 total
  • Sale

    Common Stock

    [F1][F3]
    2026-07-02$161.28/sh1,672$269,66031,565 total
  • Sale

    Common Stock

    [F1][F4]
    2026-07-02$162.01/sh1,167$189,06630,398 total
  • Sale

    Common Stock

    [F1][F5]
    2026-07-02$163.71/sh437$71,54129,961 total
  • Sale

    Common Stock

    [F1]
    2026-07-02$164.20/sh200$32,84029,761 total
Holdings
  • Common Stock

    (indirect: By Trust)
    54,382
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.
  • [F2]This transaction was executed in multiple trades ranging from $159.72 to $160.66. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades ranging from $160.74 to $161.74. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades ranging from $161.83 to $162.76. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades ranging from $163.09 to $163.95. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John Burke, Attorney-in-Fact|2026-07-07

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT